Edition:
United States

Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

2.30USD
14 Dec 2017
Change (% chg)

$-0.27 (-10.51%)
Prev Close
$2.57
Open
$2.50
Day's High
$2.50
Day's Low
$2.30
Volume
2,214
Avg. Vol
1,153
52-wk High
$7.56
52-wk Low
$2.30

Chart for

About

Kazia Therapeutics Limited, formerly Novogen Limited, is an oncology biotechnology company, which is focused on developing cancer treatments. The Company is primarily engaged in pharmaceutical research and development. It has two drug technology platforms (the Superbenzopyran (SBP) technology and Anti-tropomyosin (ATM)) yielding... (more)
No analyst recommendations are available for .

Overall

Beta: 0.49
Market Cap(Mil.): $12.92
Shares Outstanding(Mil.): 4.83
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 190.77 16.04
EPS (TTM): -- -- --
ROI: -- -11.61 35.70
ROE: -- -35.87 15.40

Competitors

Earnings vs. Estimates